HB Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,101
| Closed | -$280K | – | 911 |
|
|
2024
Q1 | $280K | Buy |
4,101
+791
| +24% | +$53.9K | ﹤0.01% | 681 |
|
|
2023
Q4 | $207K | Buy |
+3,310
| New | +$207K | ﹤0.01% | 732 |
|
|
2022
Q4 | – | Sell |
-4,452
| Closed | -$291K | – | 687 |
|
|
2022
Q3 | $291K | Sell |
4,452
-100
| -2% | -$6.54K | 0.01% | 444 |
|
|
2022
Q2 | $277K | Buy |
4,552
+750
| +20% | +$45.6K | 0.01% | 458 |
|
|
2022
Q1 | $239K | Hold |
3,802
| – | – | ﹤0.01% | 511 |
|
|
2021
Q4 | $288K | Buy |
+3,802
| New | +$288K | 0.01% | 396 |
|